在患有MDS/AML的患者中GATA2的预后意义:系统性审查和元分析

Xueya Han1, Wei Liu1, Zhongyu Kang1

  • 1Department of Blood Transfusion, Tianjin First Central Hospital, School of Medicine, Nankai University, 24 Fukang Road, Nankai, Tianjin, China.

Annals of hematology
|July 18, 2024
PubMed
概括

GATA2突变与骨髓质疏松症候群 (MDS) 和急性骨髓性白血病 (AML) 患者的生存率降低有关. 建议对这些GATA2突变的个体进行早期,积极的治疗.